Annual Drug Patent Expirations for VEREGEN
Veregen is a drug marketed by Ani Pharms and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.
Drug patent litigation for VEREGEN.
This drug has twenty-nine patent family members in twenty countries.
The generic ingredient in VEREGEN is sinecatechins. Two suppliers are listed for this compound. Additional details are available on the sinecatechins profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
